Clinical Trials Sponsored by R-Pharm

Total 7950 results

Galderma R&D

Completed

Patient Education in Adherence on Acne (PEAce)

Acne

United Kingdom
Galderma R&D

Completed

Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses (CoMet)

Actinic Keratoses

Australia
Galderma R&D

Completed

Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses (COMET2)

Actinic Keratoses

Spain, France, Germany, Netherlands, Sweden
Galderma R&D

Completed

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK (SESAME 2)

Actinic Keratoses

Germany
Galderma R&D

Completed

A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Germany, Canada, Hungary, Poland
Galderma R&D

Completed

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Psoriasis Vulgaris

United States, Canada, Belgium, Germany, Italy
Galderma R&D

Completed

Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis (Escape)

Scalp Seborrheic Dermatitis

Belgium, France, Germany, Korea, Republic of, Mexico
Galderma R&D

Completed

Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne (EDeN)

Acne Vulgaris

United States, Mauritius, Singapore
Galderma R&D

Completed

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Acne

United States
Galderma R&D

Completed

Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Rosacea

United States
Galderma R&D

Completed

A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis

Chronic Plaque Psoriasis

United States, Canada
Galderma R&D

Completed

Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis

Onychomycosis

United States
Galderma R&D

Completed

Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin

Photoaged Skin

United Kingdom
Galderma R&D

Completed

Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma (CLARA)

Melasma

Brazil, Mexico
C. R. Bard

Completed

A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair (ATLAS)

Hernia, Ventral | Incisional Hernia

United States
C. R. Bard

Completed

Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae

Arteriovenous Fistula

United States
C. R. Bard

Completed

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA) (AVeVA)

Restenosis | Stenosis

United States
Galderma R&D

Completed

Safety and Efficacy of Nemolizumab in PN

Prurigo Nodularis

Germany, Poland, France, Austria
Galderma R&D

Completed

CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris

Acne Vulgaris

United States, Germany, Hungary, Czechia
Galderma R&D

Completed

Dose-ranging Study of Nemolizumab in Atopic Dermatitis

Atopic Dermatitis

United States, France, Poland, Germany, Australia, Canada
C. R. Bard

Completed

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis (SFA ISR)

Restenosis | Femoral Artery Occlusion | Femoral Artery Stenosis

United States
C. R. Bard

Completed

Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System (REALITY III)

Peripheral Arterial Disease | Intermittent Claudication

Germany
Galderma R&D

Completed

Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis

Psoriasis

Taiwan
R&D Cardiologie

Completed

Evaluation and Comparison of Several Point-of-care Platelet Function Tests in Predicting Clinical Outcomes in Clopidogrel Pre-treated Patients Undergoing Elective PCI.

Stable Angina Pectoris

Netherlands
C. R. Bard

Terminated

Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Placement

Primary Focus: Adult Subjects Who Require PICC Placement

United States
C. R. Bard

Terminated

Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter

Vascular Access Complication

United States
C. R. Bard

Completed

Progel Vascular Sealant

Aortic Valve Stenosis | Aortic Valve Disorder | Aneurysm of Ascending Aorta | Bicuspid Valve Disorder

United States
C. R. Bard

Completed

Post-Approval Study for the FLAIR Endovascular Stent Graft (RENOVA)

Stenosis of Vascular Prosthetic Devices, Implants and Grafts

United States
C. R. Bard

Completed

AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use

Vascular Access Complication

United States
C. R. Bard

Completed

Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System (MODUS)

Indication for Peripheral Intravenous Catheterization

United States
C. R. Bard

Completed

Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP) (NASCENT)

Respiratory Failure

United States
C. R. Bard

Completed

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

Coronary Artery Stenosis

Netherlands
C. R. Bard

Completed

Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation (True™Flow)

Aortic Valve Stenosis

Germany
C. R. Bard

Completed

FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis (RESCUE)

Restenosis

United States
Unilever R&D

Completed

The Effect of a Natural Extract on Glucose Fluxes After Consumption of a Wheat Product

Healthy

Netherlands
Galderma R&D

Completed

Effect of CD07805/47 Gel in Rosacea Flushing

Rosacea

Germany
C. R. Bard

Terminated

Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters (DISTAL)

Cancer

United States
C. R. Bard

Completed

A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System

Pulmonary Embolism

United States
Galderma R&D

Completed

Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration

Healthy
Unilever R&D

Completed

Bioavailability of Iron From Savoury Food Product

Healthy | Iron Deficiency

Switzerland
Galderma R&D

Completed

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea

Rosacea

Russian Federation, France, Sweden
Unilever R&D

Completed

Post-prandial Glucose in Healthy Indian Subjects

Healthy Subjects

India
Galderma R&D

Completed

An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours (GK567)

Malodorous Infected Cutaneous Ulcer

Japan
Unilever R&D

Completed

Post-prandial Glucose in Healthy Subjects

Healthy Subjects

India
Unilever R&D

Completed

The Effect of Plant Sterols on Vascular Function

Vascular Diseases | Hypercholesterolemia

Germany
C. R. Bard

Completed

GENESIS Feasibility Study of the BARD Over-the-Wire Mesh Ablation System for the Treatment of Paroxysmal Atrial Fibrillation (GENESIS)

Paroxysmal Atrial Fibrillation

Canada, Germany, United Kingdom
C. R. Bard

Completed

RF Ablation of Atrial Fibrillation

Atrial Fibrillation

United States
Unilever R&D

Completed

Effect of Different Flour Compositions in a Carbohydrate-based Food on Rate of Exogenous Glucose Appearance in Blood

Healthy

Netherlands
C. R. Bard

Terminated

Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation (MAGELLAN)

Paroxysmal Atrial Fibrillation

United States
C. R. Bard

Completed

Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. (EVEREST)

Pulmonary Embolism | Venous Thromboembolic Disease

3

Subscribe